Sources & Demo Notes
Transparency, scope, and roadmap for the NAR proof-of-concept.
Investor / Lender Demo Notes
- This demo is designed for B-Force Demo Day.
- It is intended to explain the concept, not serve as a working clinical product.
- All participant names, health values, alerts, and reports are simulated.
- No real Apple Watch, Apple Health, wearable, or medical device is connected.
- No real patient data is collected.
- No diagnosis, treatment, emergency response, or clinical decision should be made from this demo.
- Proprietary scoring modules are intentionally hidden.
Future Development Roadmap
Phase 1
01
Target: July 2026
Demo Prototype
- Simulated participant data
- Demo Day presentation
- Stakeholder feedback collection
Phase 2
02
Target: August–September 2026
MVP Planning + Technical Scope
- Developer requirements
- Data model planning
- Participant self-check-in workflow
- Clinician dashboard requirements
- Compliance / security discovery
Phase 3
03
Target: October–December 2026
MVP Build
- Manual participant input
- Clinician dashboard
- Alert workflow
- Basic reporting
- Secure architecture planning
Phase 4
04
Target: Q1 2027
Wearable Integration Research
- Apple Health / Apple Watch feasibility
- Wearable API review
- Data permissions
- Device limitations
- Sync reliability testing
Phase 5
05
Target: Q2 2027
Pilot Planning + Validation Preparation
- Clinic / hospital partner conversations
- IRB / compliance planning
- Controlled test group design
- Clinical validation plan
- Pilot readiness review
Timeline is dependent on funding, technical partner availability, compliance review, and pilot partner readiness.
Funding Ask: $350,000 to move NAR from simulated proof-of-concept to MVP and pilot-readiness.
Evidence & Citation Placeholders
Substance use relapse and recovery research
Citation needed before investor distribution.
Wearable health monitoring research
Citation needed before investor distribution.
Recovery capital research
Citation needed before investor distribution.
Behavioral health intervention models
Citation needed before investor distribution.
Digital health privacy and compliance considerations
Citation needed before investor distribution.
Clinical validation and pilot design
Citation needed before investor distribution.
Before sharing this demo beyond Demo Day, all statistical claims, risk thresholds, and outcome projections should be supported with citations or clearly labeled as assumptions.
Protected Concept Area
Cognitive and behavioral scoring modules, the proprietary blending logic, and model weighting details are intentionally not shown in this demo. Details available during qualified follow-up discussion.
Proof-of-concept demo. Simulated data only. Not for clinical use, diagnosis, treatment, emergency response, or real-time patient monitoring.